NCT00820469 Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab Status COMPLETED Phase PHASE4
NCT00817752 Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation Status COMPLETED Phase PHASE1
NCT00777400 Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells Status WITHDRAWN Phase PHASE1/PHASE2
NCT00742300 Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases Status UNKNOWN Phase PHASE1/PHASE2
NCT00419419 Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon Status COMPLETED Phase PHASE3
NCT00035308 Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease Status COMPLETED Phase PHASE3
NCT00010387 Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease Status COMPLETED Phase PHASE2
NCT00010335 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders Status COMPLETED Phase PHASE1
NCT00001768 Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) Status COMPLETED Phase PHASE3
NCT00001291 Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions Status COMPLETED Phase N/A